Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria

Erlangga Yusuf; Alexandre P. Zavascki; Henrik Endeman; Andre C. Kalil

doi:10.1016/j.cmi.2023.08.004

Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria

Erlangga Yusuf^*, Alexandre P. Zavascki, Henrik Endeman, Andre C. Kalil

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1364-1366
Number of pages	3
Journal	Clinical Microbiology and Infection
Volume	29
Issue number	11
Early online date	11 Aug 2023
DOIs	https://doi.org/10.1016/j.cmi.2023.08.004
Publication status	Published - Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2023.08.004

Cite this

@article{65856d9d15294d9a9e0c151006bb0fa4,

title = "Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria",

author = "Erlangga Yusuf and Zavascki, {Alexandre P.} and Henrik Endeman and Kalil, {Andre C.}",

year = "2023",

month = nov,

doi = "10.1016/j.cmi.2023.08.004",

language = "English",

volume = "29",

pages = "1364--1366",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier",

number = "11",

}

Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria. / Yusuf, Erlangga; Zavascki, Alexandre P.; Endeman, Henrik et al.
In: Clinical Microbiology and Infection, Vol. 29, No. 11, 11.2023, p. 1364-1366.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria

AU - Yusuf, Erlangga

AU - Zavascki, Alexandre P.

AU - Endeman, Henrik

AU - Kalil, Andre C.

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85169891322&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2023.08.004

DO - 10.1016/j.cmi.2023.08.004

M3 - Comment/Letter to the editor

C2 - 37572830

AN - SCOPUS:85169891322

SN - 1198-743X

VL - 29

SP - 1364

EP - 1366

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 11

ER -

Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative bacteria

UN SDGs

Access to Document

Other files and links

Cite this